$0.58
+0.03(5.13%)
Mkt Cap $36M
$0.55
$1.29
52-Week Range
At a Glance
AI-generatedCytosorbents delivered modest revenue growth and significantly narrowed losses for fiscal 2025, while executing restructuring actions to advance its path to profitability.
Revenue breakdown: Single Reportable Segment (100%).
8-K
CytoSorbents Corporation received a 180-day extension from Nasdaq until September 28, 2026, to regain compliance with the $1.00 minimum bid price requirement for continued listing.$36M
Market Cap
$37M
Revenue
-$11M
Net Income
Employees149
Fundamentals
How The Business Makes Money
Revenue by Segment
Single Reportable Segment100%($73M)
Revenue by Geography
All Other Countries65.3%($95M)
DE34.1%($50M)
US0.6%($800.0K)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001175151
ISINUS23283X2062
CUSIP23283X206
Phone732 329 8885
Address305 College Road East, Princeton, NJ, 08540, US
SEC EDGAR